Compass Therapeutics, Inc.CMPXNASDAQ
LOADING
|||
Switch Symbol:
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q3 2025 | 28.57% |
| Q2 2025 | -16.67% |
| Q1 2025 | -9.09% |
| Q4 2024 | -44.36% |
| Q3 2024 | 19.79% |
| Q2 2024 | -18.75% |
| Q1 2024 | 27.27% |
| Q4 2023 | -37.50% |
| Q3 2023 | 11.11% |
| Q2 2023 | -90.68% |
| Q1 2023 | 51.79% |
| Q4 2022 | 11.00% |
| Q3 2022 | -38.71% |
| Q2 2022 | -12.01% |
| Q1 2022 | 71.68% |
| Q4 2021 | -150.00% |
| Q3 2021 | 90.65% |
| Q2 2021 | -664.29% |
| Q1 2021 | 0.00% |
| Q4 2020 | 6.67% |
| Q3 2020 | -36.36% |
| Q2 2020 | 8.33% |
| Q1 2020 | -9.09% |
| Q4 2019 | 31.25% |
| Q3 2019 | 5.88% |
| Q2 2019 | 92.09% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |